Blastomycosis is a rare fungal infection caused by inhaling spores of the fungus Blastomyces dermatitidis
Antifungal treatment can be useful for patients with severe asthma and fungal sensitisation, but this is limited by a lack of prevalence data. Two new papers aim to address this for Sweden (Backman et al) and 13 countries across Africa (Kwizera et al).
This week a team from the University of Manchester, London School of Hygiene and Tropical Medicine and GAFFI presented work at ECCMID showing the burden of fungal disease estimates for Namibia, Paraguay and Kyrgyzstan, and that fungal keratitis leads to over 600,000 blind eyes annually
A collaboration between scientists in Manchester and Uganda reveals that around 1 in 15 tuberculosis patients go on to develop chronic pulmonary aspergillosis (CPA), via cavities left by the tuberculosis. Prompt diagnosis and antifungal treatment has the potential to save many thousands of lives.